Cross-Pharma Collaboration for the Development of a Simulation Tool for the Model-Based Digital Design of Pharmaceutical Crystallization Processes (CrySiV)
Botond Szilagyi,Wei-Lee Wu,Ayse Eren,Jaron Mackey,Shivani Kshirsagar,Emoke Szilagyi,Iben Ostergaard,Haiyan Qu,Kushal Sinha,Laurie Mlinar,Daniel Pohlman,Jie Chen,Nandkishor Nere,Moussa Boukerche,Akshay Korde,Ryan Ellis,Michael Lovette,Simon Black,Anna Jawor-Baczynska,Huayu Li,Bing-Shiou Yang,Erwin Irdam,Daniel Patience,Rahn McKeown,Megan Ketchum,Daniel A. Green,Venkata Ramana Reddy,Christopher Polster,Christopher Burcham,Daniel Jarmer,Jeremy Miles Merritt,Aaron Cote,Eric Sirota,Lorenzo Codan,Jochen Schoell,Yiqing Claire Liu,Kevin P. Girard,Samir A. Kulkarni,Yihui Yang,Justin L. Quon,Zoltan K. Nagy
DOI: https://doi.org/10.1021/acs.cgd.1c00904
2021-10-05
Abstract:Precompetitive collaborations on new enabling technologies for research and development are becoming popular among pharmaceutical companies. The Enabling Technologies Consortium (ETC), a precompetitive collaboration of leading innovative pharmaceutical companies, identifies and executes projects, often with third-party collaborators, to develop new tools and technologies of mutual interest. Here, we report the results of one of the first ETC projects: the development of a user-friendly population balance model (PBM)-based crystallization simulator software. This project required the development of PBM software with integrated experimental data handling, kinetic parameter regression, interactive process simulation, visualization, and optimization capabilities incorporated in a computationally efficient and robust software platform. Inputs from a team of experienced scientists at 10 ETC member companies helped define a set of software features that guided a team of crystallization modelers to develop software incorporating these features. Communication, continuous testing, and feedback between the ETC and the academic team facilitated the software development. The product of this project, a software tool called CrySiV, an acronym for Crystallization Simulation and Visualization, is reported herein. Currently, CrySiV can be used for cooling, antisolvent, and combined cooling and antisolvent crystallization processes, with primary and secondary nucleation, growth, dissolution, agglomeration, and breakage of crystals. This paper describes the features and the numerical methods of the software and presents two case studies demonstrating its use for parameter estimation. In the first case study, a simulated data set is used to demonstrate the capabilities of the software to find kinetic parameters and its goodness of fit to a known solution. In the second case study, the kinetics of an antisolvent crystallization of indomethacin from a ternary solvent system are estimated, providing a practical example of the tool.This article has not yet been cited by other publications.
chemistry, multidisciplinary,materials science,crystallography